Mild intermittent asthma with status asthmaticus
Methodology & AI Transparency ⓘ
Mild intermittent asthma with status asthmaticus Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Mild intermittent asthma with status asthmaticus—coded clinically as J45.22 across Lungs & Asthma guidelines—combines FeNO/eosinophil Type-2 inflammation in Mild intermittent asthma with status asthmaticus (J45.22: phenotyping) with structured follow-up of Spirometry FEV1 / in Mild intermittent asthma with status asthmaticus (J45.22: FVC Ratio) (>= 0.75 (FEV1 >= 80% predicted) (J45.22)).
- 2 Real-world patient consensus: Clinical coding for Mild intermittent asthma with status asthmaticus uses ICD-10 J45.22 across Lungs & Asthma specialty care.
- 3 Typical cash cost range: Clinicians assessing Mild intermittent asthma with status asthmaticus focus on dynamic expiratory airflow in Mild intermittent asthma with status asthmaticus (J45.22: limitation) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Mild intermittent asthma with status asthmaticus: Blood Eosinophil Count [Mild intermittent asthma with status asthmaticus J45.22] (< 150 cells/uL (phenotyping marker) (J45.22)) and Spirometry FEV1 / in Mild intermittent asthma with status asthmaticus (J45.22: FVC Ratio).
Ask our AI Specialists anything about Mild intermittent asthma with status asthmaticus
What Is Mild intermittent asthma with status asthmaticus?
Mild intermittent asthma with status asthmaticus—coded clinically as J45.22 across Lungs & Asthma guidelines—combines FeNO/eosinophil Type-2 inflammation in Mild intermittent asthma with status asthmaticus (J45.22: phenotyping) with structured follow-up of Spirometry FEV1 / in Mild intermittent asthma with status asthmaticus (J45.22: FVC Ratio) (>= 0.75 (FEV1 >= 80% predicted) (J45.22)).
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Mild intermittent asthma with status asthmaticus (ICD-10 J45.22) is driven by dynamic expiratory airflow in Mild intermittent asthma with status asthmaticus (J45.22: limitation); specialists in Asthma, COPD & Respiratory Disease monitor Spirometry FEV1 / in Mild intermittent asthma with status asthmaticus (J45.22: FVC Ratio) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Mild intermittent asthma with status asthmaticus (J45.22): declining stair-climbing stamina in Mild intermittent asthma with status asthmaticus (J45.22: or frequent rescue)
- • Secondary Mild intermittent asthma with status asthmaticus clinical sign: episodic wheezing, expiratory in Mild intermittent asthma with status asthmaticus (J45.22: chest tightness, or)
- • Symptom flares in Mild intermittent asthma with status asthmaticus correlating with Blood Eosinophil Count [Mild intermittent asthma with status asthmaticus J45.22] deviation outside < 150 cells/uL (phenotyping marker) (J45.22)
- • Functional lungs & asthma impact requiring FeNO/eosinophil Type-2 inflammation in Mild intermittent asthma with status asthmaticus (J45.22: phenotyping) evaluation (J45.22)
Mild intermittent asthma with status asthmaticus Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | J45.22 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Asthma, COPD & Respiratory Disease | NLM Clinical Tables |
| Diagnostic / Lab Marker: Blood Eosinophil Count [Mild intermittent asthma with status asthmaticus J45.22] | < 150 cells/uL (phenotyping marker) (J45.22) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Spirometry FEV1 / in Mild intermittent asthma with status asthmaticus (J45.22: FVC Ratio) | >= 0.75 (FEV1 >= 80% predicted) (J45.22) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fractional Exhaled Nitric in Mild intermittent asthma with status asthmaticus (J45.22: Oxide (FeNO)) | < 25 ppb (J45.22) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Mild intermittent asthma with status asthmaticus
Treatment selection for Mild intermittent asthma with status asthmaticus depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Mild intermittent asthma with status asthmaticus)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| GLP-1RA vs. Placebo: Which Works Better for Heart failure and mildly reduced or preserved ejection fraction? GLP-1RA reduce HF exacerbations and can play a role in reducing hospitalizations, improving patient's functional status, and significantly impacting the global healthcare burden of HF. International journal of cardiology • 2025-11-01 • Meta-Analysis | N = 4,474 | 99/100 | PMID 40623630 ↗ |
| New Insights on Skin-applied tazarotene in the treatment of mild to moderate: What a 468-Participant Study Found In general, 'using the cream formulation rather than the gel formulation optimized tolerability. Cutis • 2004-10-15 • Meta-Analysis | N = 468 | 97/100 | PMID 15543714 ↗ |
| New Insights on Mineralocorticoid Receptor Antagonism with Finerenone: A New Era in the: What a 13,026-Participant Study Found We explore the emerging role of the nonsteroidal MRA finerenone as a new therapeutic opportunity to improve the risk of adverse heart and blood vessel outcomes in patients with HF and mildly reduced or preserved ejection. American journal of cardiovascular drugs : drugs, devices, and other interventions • 2025-07-15 • Phase III Randomized Trial | N = 13,026 | 96/100 | PMID 40055303 ↗ |
| New Insights on Efficacy of finerenone in patients with heart failure and mildly reduced or: What a 3,497-Participant Study Found Among patients with HFpEF/HFmrEF in FINEARTS-HF, higher baseline HR was associated with a higher risk of the primary outcome in patients with SR but not in those with AF. European journal of heart failure • 2026-05-02 • Phase III Randomized Trial | N = 3,497 | 96/100 | PMID 41771075 ↗ |
| Check Your Medicine Cabinet: Family Farmstead Dairy Announces Recall of Raw Mild Cheddar Cheese Due to Potential E. c WORCESTER, NY, October 15, 2026 - Family Farmstead Dairy of Worcester, NY is recalling specific lot of cheddar cheese because it may be contaminated with Escherichia coli O157:H7 bacteria (E. Coli O157:H7). E. coli O157:H7 causes a diarrheal illness often with FDA Drug Recalls • 2026-10-15 • FDA Recall | Multi-cohort | 95/100 | PMID FDA_RECALLS-2412744266 ↗ |
Mild intermittent asthma with status asthmaticus Patient Community & “People Like Me” Threads
Filter Mild intermittent asthma with status asthmaticus community threads and patient logs by age, biological sex, dosage, and treatment duration.